Literature DB >> 20130994

Granulocyte colony-stimulating factor enhances bone marrow mononuclear cell homing to the liver in a mouse model of acute hepatic injury.

Shi-Zhu Jin1, Xiang-Wei Meng, Xun Sun, Ming-Zi Han, Bing-Rong Liu, Xin-Hong Wang, Li-Ying Sun, Qi Huang, Rui-Bo Zhao, Xiang Ban, Hong-Ying Yu, Hong-Wei Yu.   

Abstract

BACKGROUND: Experiments have reported that granulocyte colony stimulating factor (G-CSF) can mobilize stem cells. However, few studies have examined the effect of G-CSF on bone marrow mononuclear cell (BMMC) mobilization, in particular regarding their capability to home to acutely injured liver. AIMS: The aim of this study was to evaluate the effort of G-CSF on BMMC homing to the liver following chemically-induced hepatic failure.
METHODS: BMMC were isolated from mice, pre-labeled with PKH26 and infused into the mice in which hepatic injury had been induced followed by administration of G-CSF or vehicle. Livers were studied by fluorescent microscopy after transplantation of pre-labeled BMMC.
RESULTS: PKH26 labeled cells were found in liver tissue at 102 ± 10 cells/high power field in the BMMC+G-CSF group and 30 ± 5 cells/high power field in the BMMC group, but none in the G-CSF group and the control group (P < 0.05). In the former two groups the majority of PKH26 labeled cells colocalized with proliferative cell nuclear antigen (PCNA). The number of PCNA positive cells in the BMMC+G-CSF group was 20 ± 4 cells/high power field, while in the BMMC group it was 14 ± 2 cells/high power field, in the G-CSF group 12 ± 2 cells/high power field, and 8 ± 1 cells/high power field in the control group. Moreover, albumin expression was increased in the BMMC+G-CSF treated group (149 ± 7/high power field) relative to the BMMC group (48 ± 6/high power field), the G-CSF group (44 ± 5/high power field) and the vehicle group (30 ± 6/high power field), with the former three groups showing elevated levels as compared to vehicle control (30 ± 6) (P < 0.05).
CONCLUSION: Transplanted BMMC may home to injured liver, which appears to be enhanced by G-CSF administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130994     DOI: 10.1007/s10620-009-1117-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.

Authors:  Pieternella S in 't Anker; Willy A Noort; Sicco A Scherjon; Carin Kleijburg-van der Keur; Alwine B Kruisselbrink; Rutger L van Bezooijen; Willem Beekhuizen; Roelof Willemze; Humphrey H H Kanhai; Willem E Fibbe
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941

2.  Cloning, characterization, and localization of mouse and human SPO11.

Authors:  P J Romanienko; R D Camerini-Otero
Journal:  Genomics       Date:  1999-10-15       Impact factor: 5.736

3.  G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

Authors:  Evangelia Yannaki; Evangelia Athanasiou; Angeliki Xagorari; Varnavas Constantinou; Ioannis Batsis; Panagiotis Kaloyannidis; Evangelia Proya; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Exp Hematol       Date:  2005-01       Impact factor: 3.084

4.  Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.

Authors:  Yasuo Sugano; Toshihisa Anzai; Tsutomu Yoshikawa; Yuichiro Maekawa; Takashi Kohno; Keitaro Mahara; Kotaro Naito; Satoshi Ogawa
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

5.  G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes.

Authors:  Shinya Fukuhara; Shinji Tomita; Takeshi Nakatani; Yoshinori Ohtsu; Michiko Ishida; Chikao Yutani; Soichiro Kitamura
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

6.  Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.

Authors:  Yair Gazitt; Cagla Akay
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 7.  The nature and action of granulocyte-macrophage colony stimulating factors.

Authors:  A W Burgess; D Metcalf
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

8.  Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Guilherme V Silva; Claudio T Mesquita; Luciano Belém; William K Vaughn; Fernando O D Rangel; Joao A R Assad; Antonio C Carvalho; Rodrigo V C Branco; Maria I D Rossi; Hans J F Dohmann; James T Willerson
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

Review 9.  Proliferating cell nuclear antigen (PCNA): a dancer with many partners.

Authors:  Giovanni Maga; Ulrich Hubscher
Journal:  J Cell Sci       Date:  2003-08-01       Impact factor: 5.285

10.  Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium.

Authors:  Ahmad Y Sheikh; Shu-An Lin; Feng Cao; Yuan Cao; Koen E A van der Bogt; Pauline Chu; Ching-Pin Chang; Christopher H Contag; Robert C Robbins; Joseph C Wu
Journal:  Stem Cells       Date:  2007-07-12       Impact factor: 6.277

View more
  14 in total

Review 1.  Stem cell recruitment after injury: lessons for regenerative medicine.

Authors:  Robert C Rennert; Michael Sorkin; Ravi K Garg; Geoffrey C Gurtner
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

2.  CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure.

Authors:  Zhihong Wan; Shaoli You; Yihui Rong; Bing Zhu; Aimin Zhang; Hong Zang; Long Xiao; Guoming Xie; Shaojie Xin
Journal:  Dig Dis Sci       Date:  2012-10-25       Impact factor: 3.199

3.  Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation.

Authors:  Silvia Gaia; Antonella Olivero; Antonina Smedile; Marco Ruella; Maria Lorena Abate; Maurizio Fadda; Emanuela Rolle; Paola Omedè; Paola Bondesan; Roberto Passera; Alessandra Risso; Manuela Aragno; Alfredo Marzano; Alessia Ciancio; Mario Rizzetto; Corrado Tarella
Journal:  Hepatol Int       Date:  2013-10-11       Impact factor: 6.047

4.  Stem cell-based therapies for liver diseases: state of the art and new perspectives.

Authors:  Anna Chiara Piscaglia; Mariachiara Campanale; Antonio Gasbarrini; Giovanni Gasbarrini
Journal:  Stem Cells Int       Date:  2010-09-01       Impact factor: 5.443

Review 5.  Bone marrow derived stem cells for the treatment of end-stage liver disease.

Authors:  Cristina Margini; Ranka Vukotic; Lucia Brodosi; Mauro Bernardi; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

6.  Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke.

Authors:  Xue-mei Zhang; Fang Du; Dan Yang; Chun-jiang Yu; Xiang-nan Huang; Wei Liu; Jin Fu
Journal:  BMC Neurosci       Date:  2010-10-25       Impact factor: 3.288

7.  Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice.

Authors:  Xue-Mei Zhang; Fang Du; Dan Yang; Rui Wang; Chun-Jiang Yu; Xiang-Nan Huang; Hong-Yan Hu; Wei Liu; Jin Fu
Journal:  BMC Neurosci       Date:  2011-06-24       Impact factor: 3.288

8.  The role of chemokines in acute liver injury.

Authors:  Yedidya Saiman; Scott L Friedman
Journal:  Front Physiol       Date:  2012-06-20       Impact factor: 4.566

9.  Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization.

Authors:  Dae Won Jun; Kiseok Jang; Ho Hyun Nam; Waqar Khalid Saeed; Jai Sun Lee; Hyeon Tae Kang; Yeon Ji Chae
Journal:  Oncotarget       Date:  2017-07-04

10.  Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.

Authors:  Laurent Spahr; Yves Chalandon; Sylvain Terraz; Vincent Kindler; Laura Rubbia-Brandt; Jean-Louis Frossard; Romain Breguet; Nicolas Lanthier; Annarita Farina; Jakob Passweg; Christoph D Becker; Antoine Hadengue
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.